Development and validation of a machine learning model to predict the daily risk of febrile neutropenia in patients with AML undergoing chemotherapy

Anna Mervaala-Muroke, Laura Toivanen, Pia Ettala, Riikka Räty, Mikko Keränen, Oscar Brück
Communications Medicine · Springer Nature · 2026-11-13 · DOI: 10.1038/s43856-026-02001-x

Аннотация

Communications Medicine, Published online: 13 November 2026; doi:10.1038/s43856-026-02001-x Development and validation of a machine learning model to predict the daily risk of febrile neutropenia in patients with AML undergoing chemotherapy

Читать у издателя →

Похожие статьи